Compare LFMD & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LFMD | STXS |
|---|---|---|
| Founded | 1994 | 1990 |
| Country | United States | United States |
| Employees | 336 | N/A |
| Industry | Medical/Nursing Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 191.6M | 201.6M |
| IPO Year | N/A | 2004 |
| Metric | LFMD | STXS |
|---|---|---|
| Price | $4.00 | $1.85 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 2 |
| Target Price | ★ $9.14 | $4.00 |
| AVG Volume (30 Days) | ★ 1.2M | 394.8K |
| Earning Date | 03-09-2026 | 03-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 16.67 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $29,346,617.00 |
| Revenue This Year | $17.76 | $34.08 |
| Revenue Next Year | $17.66 | $35.18 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.60 | $1.54 |
| 52 Week High | $15.34 | $3.59 |
| Indicator | LFMD | STXS |
|---|---|---|
| Relative Strength Index (RSI) | 59.34 | 36.63 |
| Support Level | $3.43 | N/A |
| Resistance Level | $4.20 | $2.52 |
| Average True Range (ATR) | 0.35 | 0.12 |
| MACD | 0.06 | -0.01 |
| Stochastic Oscillator | 60.81 | 17.36 |
LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.